Devices using radio frequencies have been reported to be useful in heating skin at depths of a few to many millimeters. Such treatments may produce tissue remodeling or shrinkage, resulting in clinically useful changes in the morphology or appearance of the skin. The RF power can be problematic to apply to skin in that the contact electrode geometries and superficial hydration of the skin can greatly affect the coupling of power into the skin. Attendant complications include superficial burns, uneven application of energy. One reference which discusses the uses of a device for applying radio frequency to the skin is U.S. Pat. No. 6,453,202 U.S. Pat. No. 6,453,202, entitled Method and apparatus for controlled contraction of collagen tissue
Some prior system have provided for a combination of a light source in combination with use of RF electrodes to obtain relatively deep heating of dermatological issue. Additionally, some efforts have been directed toward developing systems utilizing a filament light source to apply light energy to the skin to achieve collagen shrinkage. However, prior systems have exhibited different significant limitations.
a-2b show views of an embodiment of a system herein.
a-3b show views of an embodiment of handpiece of a system herein.
One embodiment herein provides a number of advantages over some prior systems, such as no electrical contact with patient and reduced sensitivity to surface hydration. Also using a relatively broadband light source allows for tailored spectral profiles by filtering. Further, an embodiment herein provides for a broadband spectrum light source, which can be driven to output a range of different treatment fluences, and allows for control of the skin temperature to reduce the risk of unwanted thermal injury.
The device herein can use an incandescent lamp with significant optical output in the near-infrared range (NIR) from around 750 nm to 3000 nm. The lamp can be a quartz-tungsten-halogen lamp (“QTH”), but other, longer wavelength lamps may be useful (e.g. ceramic or carbon elements). A housing serves to couple NIR light to skin. The lamp is driven with high current supply, and could potentially utilize a modified version of the high voltage power supply described in the pending patent application filed Jan. 27, 2003 DERMATOLOGICAL TREATMENT FLASHLAMP DEVICE AND METHOD, U.S. application Ser. No. 10/351,981, which is incorporated herein by reference.
The desired skin absorbance profile is largely determined by water-based absorption in the NIR range, because the dermal layers targeted are generally located 1 to several mm deep.
In general, different effects due to collagen shrinkage can be achieved by controlling the temperature profile in tissue being treated. In some circumstances a treatment may target both relatively shallow skin tissue, including possibly tissue in the epidermal layer, and to also heat deeper tissue in the dermal layer. In some other circumstances the treatment can be targeted at heating the dermal layer in the range of 1-6 mm, while minimizing the heating the upper dermal layer and the epidermal layer. Regardless of the specific treatment, it is generally desired to provide for some relatively deep tissue heating in the dermal layer.
To produce deep tissue heating and potential remodeling, or collagen shrinkage, a relatively large volume of skin must be heated. Associated thermal relaxation times are measured in 100 s to 1000 s of milliseconds. Existing art using lamps to heat skin is largely limited to volumes relaxation times below 1000 ms. Thermal relaxation time for deep bulk skin heating will allow exposures >1 second, and in general to deposit sufficient NIR energy, exposure times will be >1 second. Thus, as recognized herein a device may then be turned on for as long as several seconds to produce the desired thermal profile, said profile is based on the knowledge that tissue held at temperatures above 50° C., and preferably above 60° C., for any significant length of time will experience thermal damage, and in the case of collagen this thermal damage can result in remodeling or shrinkage.
A simple calculation provides a rough illustration of the heating required to produce collagen-changing temperatures. For this calculation consider a cylindrical slug of water 3 mm thick and 6 mm diameter and having a thermal relaxation time of approximately 10 seconds. So, heating such a volume could happen more or less adiabatically in a second. If the goal is to pre-heat skin (water) by 20 C in this time, this volume of water (approximately 0.1 cm3) would require (20 C)(4 J/C*cm3)(0.1 cm3)=approx. 8 J. That is 8 J/1 sec=8 watts. Assume the electrical to delivered optical efficiency of the light source is 5%, then 160 watts of electrical power is required. To obtain this efficiency, the source can be smaller in its dimensions (e.g. width) than the treatment snot size (which is approximately 6 mm in diameter). So, if it is a filament, it would ideally have a minimum electrical rating of at least 200 watts and be only a few mm in size.
In one embodiment, a source delivering peak powers in the NIR between 10 and 100 W per cm2 is therefore required. Many generally available 600-1000 W quartz-tungsten-halogen lamps operated at rated power are unlikely to be useful as direct sources, since typical power densities at the lamp envelope are on the order of ˜1000 W/20 cm^2=50 W/cm^2, with the power density or irradiance falling rapidly with distance. The NIR portion of this results in power-in-band densities at the envelope in the low 10's of W/cm^2. Getting higher power densities can be achieved through utilization of different possible techniques. One possibility is using a filament light source for a limited life of operation and overdriving the filament lamp. Another option, which could be used alone or in conjunction with overdriving the filament lamp is collecting the output light from the entire envelope filament lamp and directing it to skin by means a reflector. Another option which could be used in combination with the above options, or alone, is employing water cooling of the quartz envelope of the lamp to enable the use of smaller lamp envelopes.
Light sources other than filament light sources could also be used, but one of the challenges is finding an economical light source that outputs light of spectrum which is useful for heating water, or more specifically for outputting light across desired parts of the NIR range. For example, it is known that Nd:YAG laser light penetrates too deeply to effectively heat water in skin at appropriate depths to perform skin remodeling. The effective penetration depth is a function of the reduced scattering coefficient and the absorption strength of (mainly) water in skin. It is desirable to use somewhat more shallow penetrating light by seeking a waveband in which absorption is somewhat stronger than 1064 nm in water and in which scattering is no greater than the 1064 nm wavelength in skin. Light falling between 950 and 1400 nm has an absorption depth in water that varies between 1 and 28 mm. Taking into account scattering in a simple model, the effective penetration of NIR light in skin in this wavelength range varies from approximately 0.3 to 2.0 mm. Filtering the NIR light produced by a filament lamp can result in an effective penetration depth (function of scattering length and absorption depth) that can be tailored to aid in creating a desired thermal depth profile in tissue being treated. However, no matter what the spectral shape may be, the light intensity in tissue, and the absorption and temperature profiles can only have a shape that is a sum of decaying exponential curves, since the absorption characteristic of each wavelength in skin follows a Beer's Law like profile. The consequence is that the thermal profile has the same basic shape, and that the spectral profile can only alter the general depth and strength of a Beer's Law-like thermal profile.
Useful bands for providing thermal remodeling can include 1150-1400 nm, and perhaps 1500-1850 nm, and in fact light up to 3000 nm range can be beneficial. In the former, scattering is somewhat reduced with respect to 1064 nm light in water, and the absorption depth in water is deep to moderate, ranging from 4-12. Considering the optical penetration depth that applies in skin, including the effects of scattering, the actual depth of penetration is approximately 3 mm. In the latter, scattering is significantly reduced compared to 1064 nm in water, and the absorption depth is relatively shallow (1-2 mm). Light from 1350-1550 nm is strongly absorbed and will only contribute to relatively deep epidermal heating.
In one mode of treatment the desired result is to produce higher temperatures in deeper thermal layers relative to the temperature at the epidermis. Heat is primarily deposited in a Beer's Law type profile, which subsequently transfers heat to the bulk of the skin. Absent some cooling applied to the surface of the skin, the application of light energy would generally be higher in the epidermis than in the dermis.
a-2b and
a shows the system 400 the system 400 includes a filament lamp 402, and surrounding the filament lamp is a flow tube 408. A housing is 412 is provided, and light from the filament light is transmitted through other optical components such as a filter 422 and a sapphire block 420. The sapphire block 420 is cooled using thermoelectric coolers 428. The system also includes an LED 434 to indicate when tissue is being treated.
a-3b illustrate an embodiment of an ergonomic handpiece 300 with the filament light system disposed therein. The handpiece can consist of molded plastic pieces, or other suitable material. As shown the handpiece 300 has two molded plastic pieces 304 and 306. A cavity is formed between the molded plastic pieces, and the filament lamp system 400 is disposed in this cavity. Two apertures are providing the handpiece. One aperture is covered with a lens 302 through with light from the LED 434 is transmitted. The second aperture allows the sapphire block 420 to protrude from the handpiece so that it can be pressed against the skin. Epoxy can be applied to the seam between molded plastic pieces and the sapphire block to improve the seal between the sapphire and the plastic.
The filament lamp and the flow tube are disposed in a housing 412. The housing can be formed of a metal such as aluminum. The inner wall of the of the housing can be coated with a highly reflective metal, or it could be highly polished aluminum. In one embodiment a highly reflective gold coating is provided, where gold is used because it is highly reflective for NIR light. The housing is provided with a small aperture 414 which allows for a photodetector 416 to be disposed such that it can sense the light output power transmitted by through the flow tube 408. Depending on the sensitivity of the photodetector, and the output power, the photodector can be provided with an attenuator 418. The reflective housing is coupled to a sapphire block 420. A filter 422 can be provided such that additional undesired light can be filtered out prior to transmitting light from the reflective housing 412 into the sapphire block 420. In one embodiment the filter 422 is a non absorbing NIR and IR transmitting wavelength filter. The interface between the filter 422 and the sapphire block 420 is provided with an anti reflecting coating on the surface of the sapphire block to minimize power loss which can occur as light is transmitted through the filter 422 into the sapphire block. The lateral sides of the sapphire block 420 can be coated with metal surfaces 426. These metal surfaces should be as reflective as possible to minimize losses as the light is transmitted through the sapphire block. It should be recognized that an embodiment of the system might be implemented without the metal coating on the sides, and the total internal reflection of the sapphire block could suffice, so long as other elements were not in direct contact with the sapphire block. In one embodiment the metal used is Aluminum, as this metal has reasonably good reflective properties and easily adheres to the surface of the sapphire block. A cooling system is provided to control the temperature of the sapphire block, and the system can use thermoelectric coolers disposed on the metal surfaces 426. These thermoelectric coolers 428 operate to control the temperature of the sapphire block 420. The operation of thermoelectric coolers, which is known in the art, is such that by application of the electrical current to the thermoelectric cooler, one side of the thermoelectric cooler can be made cooler, while the other side of the thermoelectric cooler becomes hotter forming an electrically driven heat pump. In the embodiment shown, the cool side of the thermoelectric cooler is adjacent to the sapphire block. Additionally, although not shown in
As discussed above the umbilical cable connects to the lamp system to provide control signals, electrical power and cooling fluid to the system 400.
To achieve the type of tissue heating described above consideration must be given to the temperature of the sapphire block and the driving of the filament lamp. When a user has activated the filament hand piece, by for example stepping on the activation switch 1016, the controller and power supply coupled to the filament lamp hand piece by the umbilical cable are activated to provide a treatment. In one embodiment the user will be able select an amount of fluence for a treatment exposure using the user interface 1008. Once the user has selected an amount of fluence, the controller will determine how long the filament light source will be activated to generate light to output the desired fluence. The system is designed to provide a fluence range of from 10 J/cm2 to 50 J/cm2. Of course these amounts could be modified if desired. Once the user has selected the desired amount of fluence, the hand piece 1014 is positioned so that the sapphire window is against the area of skin to which the exposure is to be applied. The user can then step on an activation pedal which will cause the treatment to begin. Upon stepping on the activation pedal, an LED 434 will light to indicate that the treatment has begun and that the user should not remove, or move, the handpiece and sapphire window relative to the area of patient's skin being treated. Initially, the system will operate to apply electrical current to the thermoelectric coolers and the temperature of the sapphire block will be brought to a treatment temperature. In one embodiment the treatment temperature is 20° C., but this could be set to a different temperature. The cooled sapphire block will continue to be pressed against the patient's skin for the initial cooling period where the sapphire will operate to cool the surface of the patient's skin. In one embodiment this initial cooling period will last for period of approximately 1 second. After approximately 1 second the power supply will operate to provide electrical energy to the filament of the filament lamp for a period of time until the desired fluence as been delivered to the patient's tissue. Depending on the desired fluence light will be transmitted from the filament to the patient's skin for a period of time ranging from slight more than 1 second, an appropriate minimum could be for example around 1.2 seconds, and an appropriate maximum could be around 5 seconds. As will be discussed in more detail below, the power supply will stop applying electrical current approximately 1 second prior to the end of the treatment exposure and the hot filament light will continue to emit light until it has cooled sufficiently. The amount of time for which the filament radiates after current application is stopped depends on the thermal mass of the filament and the operating filament temperature, and can range form 0.1 to 2 seconds. During the application of the light from the filament lamp, the cooling system including the thermoelectric coolers will continue to cool the sapphire block, ideally keeping the temperature at the initial treatment temperature. After the filament light has stopped outputting the treatment exposure, the cooling system will continue to cool the sapphire block for a post treatment exposure time period, and the sapphire block will operate to dissipate heat from the patient's skin. The LED 434 will remain lit through the initial cooling time, the time when the treatment exposure is being applied, and through the post cooling time period. By keeping the LED lit, the user will know not to remove the hand piece and the sapphire block until the treatment exposure has concluded, and the post cooling time period has ended. In addition to the LED turning off to signal the end of a treatment, an audible signal could be provide to indicate to user that a treatment has been completed.
The filament can also be driven continuously by a supply, it is not a requirement to pulse the filament current at intervals during the treatment. This was actually a method developed to obtain filament capability using the same power supply that drives flashlamps. Other variations and different methods could be utilized such as providing a higher current during the preheat phase of the pulse, in order to bring the lamp up to heat quickly. This could be combined into one long pulse with higher current in the beginning and lower current at the end. An alternate control method would be to control the voltage applied to the lamp. The voltage would ramp up at a controlled rate to limit the inrush current. Alternately the voltage control would be a step applied and the current limit of the supply would limit the current.
The above described operation of the power supply driving a filament light source, illustrates an aspect of an embodiment of the present system. Specifically, a filament light source is normally considered a relatively low current, low voltage device. However, the filament light source can be driven with the same power supply which is used to supply high current and high voltage that is required to drive a flashlamp. As describe above the ability to control the power supply to short pulses of relatively high current, allows for the controllable power supply to drive the filament light source in a manner for providing effective treatments.
In another embodiment of the system herein, the filament lamp could be driven with lower current power supply which would apply a more continuous, but lower amplitude current to drive the filament. As one of skill in the art will recognize a variety of different power supplies could be used to drive the filament lamp.
In an embodiment herein, the controller of the power supply 1112 receives signals originating from the user interface 1114 and possibly sensors 1116 in the hand piece management unit which can determine when the handpiece 1102 has been removed from a seated position, and based on these signals determines how to drive the filament lamp when the user activates the filament lamp, by stepping on a foot pedal switch for example.
The operation of the power supply will be described in the context of the situation where a user has removed the handpiece 1102 from a hand piece management unit, and initiated the activation of the filament lamp 1104 of the hand piece 1102. In this situation when the hand piece 1102 is removed from a resting or seated position and activated the filament lamp, the operation described above will be performed.
The energy storage capacitor 1122 is charged to by the main electrical supply 1134 to a level allowing the desired energy to be delivered without unacceptable lamp voltage droop, where driving the filament lamp, at the desired current. When switch 1124 is closed current ramps up current through the filament lamp 1104, inductor 1126, and switch 1124. When the appropriate output power or current is reached, the controller 1112 opens the switch 1124 and the current now diverts to the diode 1128. When the current flow or output power drops to an appropriate level the controller 1112 again turns on the switch 1124 and the cycle repeats until a pulse is complete.
This toggling of switch 1124 on and off during a treatment exposure results from the photodiode 1132, or use of a voltage sensing circuit, determining that the optical power has reached a maximum value, and in response the controller opens the switch, and when the optical power drops to a low target level the switch closes, which increase the current through the filament lamp. It should be noted that as discussed in connection with
Given the ratio of the diameter of the tube to relative to the coil in the embodiment of the lamp discussed above, and the amount of current which is used to generate a treatment exposure, traditional air cooling would not be sufficient to keep the lamp cool enough so that it would not become damaged and fail. Thus, the flow tube and liquid cooling discussed above is utilized to cool the lamp.
It should be recognized that the filament light source discussed herein is advantageous over some other light sources in that it is relatively inexpensive, and outputs a broad spectrum of light in the NIR range. At present flashlamps do not appear to provide as good a source for producing a broad range of power in the NIR spectrum, but some flashlamps might be suitable to produce such a range of light, and could be considered for use in a system for providing deep thermal heating.
While various embodiments of the present invention have been described above, it should be understood that they have been presented by way of example, and not limitation. It will be apparent to persons skilled in the relevant art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention. This is especially true in light of technology and terms within the relevant art(s) that may be later developed. Thus, the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.
The present application claims benefit from U.S. Provisional Patent Application Ser. No. 60/540,981, filed Jan. 30, 2004, entitled SYSTEM AND METHOD FOR FLEXIBLE ARCHITECTURE FOR DERMATOLOGICAL TREATMENTS UTILIZING MULTIPLE LIGHT SOURCES, AND FILAMENT LIGHT SOURCE TO BE USED IN COMBINATION WITH THE SYSTEM AND METHOD FOR FLEXIBLE ARCHITECTURE FOR DERMATOLOGICAL TREATMENTS, which is incorporated herein by reference, and the present application claims benefit from U.S. Provisional Patent Application Ser. No. 60/497,745, filed Aug. 25, 2003, entitled OPTICAL DEVICE FOR HEATING SKIN USING NIR LIGHT TO PRODUCE TISSUE SHRINKAGE, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1800277 | Boerstler | Apr 1931 | A |
634113 | Riley | Mar 1950 | A |
2699771 | Rüttger-Pelli | Jan 1955 | A |
3327712 | Kaufman et al. | Jun 1967 | A |
3538919 | Meyer | Nov 1970 | A |
3648706 | Holzer | Mar 1972 | A |
3693623 | Harte et al. | Sep 1972 | A |
3834391 | Block | Sep 1974 | A |
3867948 | Kallenborn | Feb 1975 | A |
3900034 | Katz et al. | Aug 1975 | A |
4020383 | Labadini et al. | Apr 1977 | A |
4022534 | Kishner | May 1977 | A |
4122853 | Smith | Oct 1978 | A |
4233493 | Nath | Nov 1980 | A |
4298005 | Mutzhas | Nov 1981 | A |
4388924 | Weissman et al. | Jun 1983 | A |
4461294 | Baron | Jul 1984 | A |
4505545 | Salia-Munoz | Mar 1985 | A |
4539987 | Nath et al. | Sep 1985 | A |
4608978 | Rohr | Sep 1986 | A |
4608990 | Elings | Sep 1986 | A |
4617926 | Sutton | Oct 1986 | A |
4658823 | Beddoe et al. | Apr 1987 | A |
4667658 | Guibert | May 1987 | A |
4686986 | Fenyö et al. | Aug 1987 | A |
4717863 | Zeiler | Jan 1988 | A |
4733660 | Itzkan | Mar 1988 | A |
4747660 | Nishioka et al. | May 1988 | A |
4757431 | Cross et al. | Jul 1988 | A |
4784135 | Blum et al. | Nov 1988 | A |
4813412 | Yamazaki et al. | Mar 1989 | A |
4819669 | Politzer | Apr 1989 | A |
4829262 | Furumoto | May 1989 | A |
4860172 | Schlager et al. | Aug 1989 | A |
4884568 | Hahn | Dec 1989 | A |
4917084 | Sinofsky | Apr 1990 | A |
4930504 | Diamantopoulos et al. | Jun 1990 | A |
4950880 | Hayner | Aug 1990 | A |
4976709 | Sand | Dec 1990 | A |
5000752 | Hoskin et al. | Mar 1991 | A |
5057104 | Chess | Oct 1991 | A |
5059192 | Zaias | Oct 1991 | A |
5139494 | Freiberg | Aug 1992 | A |
5161526 | Hellwing et al. | Nov 1992 | A |
5182857 | Simon | Feb 1993 | A |
5207671 | Franken et al. | May 1993 | A |
5217455 | Tan | Jun 1993 | A |
5226907 | Tankovich | Jul 1993 | A |
5258989 | Raven | Nov 1993 | A |
5259380 | Mendes et al. | Nov 1993 | A |
5282797 | Chess | Feb 1994 | A |
5290273 | Tan | Mar 1994 | A |
5304169 | Sand | Apr 1994 | A |
5304170 | Green | Apr 1994 | A |
5312395 | Tan et al. | May 1994 | A |
5320618 | Gustafsson | Jun 1994 | A |
5336217 | Buys et al. | Aug 1994 | A |
5337741 | Diamond | Aug 1994 | A |
5344418 | Ghaffari | Sep 1994 | A |
5344434 | Talmore | Sep 1994 | A |
5374265 | Sand | Dec 1994 | A |
5397327 | Koop et al. | Mar 1995 | A |
5405368 | Eckhouse | Apr 1995 | A |
5409479 | Dew et al. | Apr 1995 | A |
5425728 | Tankovich | Jun 1995 | A |
5441531 | Zarate et al. | Aug 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5474549 | Ortiz et al. | Dec 1995 | A |
5486172 | Chess | Jan 1996 | A |
5511563 | Diamond | Apr 1996 | A |
5522813 | Trelles | Jun 1996 | A |
5527350 | Grove et al. | Jun 1996 | A |
5569979 | Scott et al. | Oct 1996 | A |
5572091 | Langer et al. | Nov 1996 | A |
5591157 | Hennings et al. | Jan 1997 | A |
5595568 | Anderson et al. | Jan 1997 | A |
5611795 | Slatkine et al. | Mar 1997 | A |
5620478 | Eckhouse | Apr 1997 | A |
5660836 | Knowlton | Aug 1997 | A |
5683380 | Eckhouse et al. | Nov 1997 | A |
5735844 | Anderson et al. | Apr 1998 | A |
5755753 | Knowlton | May 1998 | A |
5769844 | Ghaffari | Jun 1998 | A |
5769878 | Kamei | Jun 1998 | A |
5782895 | Zarate et al. | Jul 1998 | A |
5807261 | Benaron et al. | Sep 1998 | A |
5810801 | Anderson et al. | Sep 1998 | A |
5814040 | Nelson et al. | Sep 1998 | A |
5820625 | Izawa et al. | Oct 1998 | A |
5830208 | Muller | Nov 1998 | A |
5843074 | Cocilovo | Dec 1998 | A |
5843143 | Whitehurst | Dec 1998 | A |
5849029 | Eckhouse et al. | Dec 1998 | A |
5860967 | Zavislan et al. | Jan 1999 | A |
5885274 | Fullmer et al. | Mar 1999 | A |
5919219 | Knowlton | Jul 1999 | A |
5964749 | Eckhouse et al. | Oct 1999 | A |
5989283 | Wilkens | Nov 1999 | A |
6015404 | Altshuler et al. | Jan 2000 | A |
6050990 | Tankovich et al. | Apr 2000 | A |
6080146 | Altshuler et al. | Jun 2000 | A |
6080147 | Tobinick | Jun 2000 | A |
6096029 | O'Donnell, Jr. | Aug 2000 | A |
6096066 | Chen et al. | Aug 2000 | A |
6120497 | Anderson et al. | Sep 2000 | A |
6168590 | Neev | Jan 2001 | B1 |
6171332 | Whitehurst | Jan 2001 | B1 |
6228074 | Almeida | May 2001 | B1 |
6235015 | Mead, III et al. | May 2001 | B1 |
6241753 | Knowlton | Jun 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6280438 | Eckhouse et al. | Aug 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6311090 | Knowlton | Oct 2001 | B1 |
6319273 | Chen et al. | Nov 2001 | B1 |
6334074 | Spertell | Dec 2001 | B1 |
6338731 | Laufer et al. | Jan 2002 | B1 |
6375672 | Aksan et al. | Apr 2002 | B1 |
6377855 | Knowlton | Apr 2002 | B1 |
6381498 | Knowlton | Apr 2002 | B1 |
6383176 | Connors et al. | May 2002 | B1 |
6387089 | Kreindel et al. | May 2002 | B1 |
6402739 | Neev | Jun 2002 | B1 |
6405090 | Knowlton | Jun 2002 | B1 |
6413253 | Koop et al. | Jul 2002 | B1 |
6413268 | Hartman | Jul 2002 | B1 |
6436094 | Reuter | Aug 2002 | B1 |
6443978 | Zharov | Sep 2002 | B1 |
6453202 | Knowlton | Sep 2002 | B1 |
6461866 | Whitehurst | Oct 2002 | B1 |
6482199 | Neev | Nov 2002 | B1 |
6485484 | Connors et al. | Nov 2002 | B1 |
6508813 | Altshuler | Jan 2003 | B1 |
6511475 | Altshuler et al. | Jan 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6524329 | Benedict | Feb 2003 | B1 |
6558372 | Altshuler | May 2003 | B1 |
6558381 | Ingle et al. | May 2003 | B2 |
6569155 | Connors et al. | May 2003 | B1 |
6602275 | Sullivan | Aug 2003 | B1 |
6605080 | Altshuler et al. | Aug 2003 | B1 |
6613040 | Tankovich et al. | Sep 2003 | B2 |
6648904 | Altshuler et al. | Nov 2003 | B2 |
6653618 | Zenzie | Nov 2003 | B2 |
6659999 | Anderson et al. | Dec 2003 | B1 |
6663620 | Altshuler et al. | Dec 2003 | B2 |
6723090 | Altshuler et al. | Apr 2004 | B2 |
6743222 | Durkin et al. | Jun 2004 | B2 |
6749624 | Knowlton | Jun 2004 | B2 |
6920883 | Bessette et al. | Jul 2005 | B2 |
6997923 | Anderson et al. | Feb 2006 | B2 |
7033349 | Key | Apr 2006 | B2 |
7147654 | Baumgardner et al. | Dec 2006 | B2 |
7220254 | Altshuler et al. | May 2007 | B2 |
7491222 | Holjo et al. | Feb 2009 | B2 |
20020019625 | Azar | Feb 2002 | A1 |
20020055092 | Hochman | May 2002 | A1 |
20020091377 | Anderson et al. | Jul 2002 | A1 |
20020128635 | Altshuler et al. | Sep 2002 | A1 |
20020161357 | Anderson et al. | Oct 2002 | A1 |
20020173780 | Altshuler et al. | Nov 2002 | A1 |
20020198575 | Sullivan | Dec 2002 | A1 |
20030004499 | McDaniel | Jan 2003 | A1 |
20030023283 | McDaniel | Jan 2003 | A1 |
20030028228 | Sand | Feb 2003 | A1 |
20030032900 | Ella | Feb 2003 | A1 |
20030032950 | Altshuler et al. | Feb 2003 | A1 |
20030036751 | Anderson et al. | Feb 2003 | A1 |
20030045916 | Anderson et al. | Mar 2003 | A1 |
20030055414 | Altshuler et al. | Mar 2003 | A1 |
20030057875 | Inochkin et al. | Mar 2003 | A1 |
20030065313 | Koop et al. | Apr 2003 | A1 |
20030065314 | Altshuler et al. | Apr 2003 | A1 |
20030069618 | Smith, III et al. | Apr 2003 | A1 |
20030125788 | Long | Jul 2003 | A1 |
20030130709 | D.C. et al. | Jul 2003 | A1 |
20030195494 | Altshuler et al. | Oct 2003 | A1 |
20030199859 | Altshuler et al. | Oct 2003 | A1 |
20040010298 | Altshuler et al. | Jan 2004 | A1 |
20040024388 | Altshuler | Feb 2004 | A1 |
20040034319 | Anderson et al. | Feb 2004 | A1 |
20040093042 | Altshuler et al. | May 2004 | A1 |
20040143247 | Anderson et al. | Jul 2004 | A1 |
20040147985 | MacFarland et al. | Jul 2004 | A1 |
20050049658 | Connors et al. | Mar 2005 | A1 |
20050107850 | Vaynberg et al. | May 2005 | A1 |
20050107852 | Levernier et al. | May 2005 | A1 |
20050143793 | Korman et al. | Jun 2005 | A1 |
20060052847 | Davenport et al. | Mar 2006 | A1 |
Number | Date | Country |
---|---|---|
968854 | Jun 1975 | CA |
1041610 | Oct 1978 | CA |
33 47 730 | Jul 1985 | DE |
3803763 | Aug 1989 | DE |
0 565 331 | Apr 1993 | EP |
2 360 946 | Oct 2001 | GB |
4-98795 | Mar 1992 | JP |
4-322668 | Nov 1992 | JP |
5-329218 | Dec 1993 | JP |
WO 8602783 | May 1986 | WO |
WO 8900871 | Feb 1989 | WO |
WO 9515725 | Jun 1995 | WO |
WO 9622813 | Aug 1996 | WO |
WO 9737723 | Oct 1997 | WO |
WO 9824514 | Jun 1998 | WO |
WO 9838933 | Sep 1998 | WO |
WO 9851235 | Nov 1998 | WO |
WO 9907438 | Feb 1999 | WO |
WO 9911324 | Mar 1999 | WO |
WO 0054685 | Sep 2000 | WO |
WO 0054685 | Sep 2000 | WO |
Entry |
---|
Jacques, “Skin Optics”; Oregon Medical Laser Center News. Jan. 1998; http://omlc.ogi.edu/news/jan98/skinoptics.html. |
H. Kubota., “Atrial Ablation With an IRK-151 Infrared Coagulator,” Annals of Thoracic Surgery, vol. 66, No. 1, Jul. 1988, pp. 95-100. |
In re U.S. Appl. No. 10/351,981, filed Jan. 27, 2003, by Dean A. MacFarland, entitled: Dermatological Treatment Flashlamp Device and Method, 19 two-sided pages in length. |
R.M. Adrian, “Treatment of Facial Telangiectasia Using the VersaPulse® Variable Pulse Width Frequency Doubled Neodymium:YAG Laser: A Case Report,” 2 pages in length. |
J.C. Allain et al., “Isometric Tensions Developed During the Hydrothermal Swelling of Rat Skin,” Connective Tissue Research, vol. 7, pp. 127-133 (1980). |
R.R. Anderson, “Clinical Use of the Lightsheer Diode Laser System,” (reprinted with permission from Harvard Medical School, Mar. 1998) from the website located at http://www.lasertraining.com/med-8.htm, printed Sep. 15, 1998, 5 pages long. |
R.R. Anderson et al., International Advances in Surgical Oncology (vol. 5), section entitled “Lasers in Dermatology Provide a Model for Exposing New Applications in Surgical Oncology,” publisher Alan R. Liss, Inc. (1982), pp. 341-358. |
W.F. Coulson et al., “Nonablative Laser Treatment of Facial Rhytides: Animal Study,” Abstract of BiOS '98 Symposium [Cutaneous Applications of Lasers], Jan. 24-30, 1998 in San Jose, CA, one page in length. |
L. Goldman, “Comparison of the Biomedical Effects of the Exposure of Human Tissues to Low and High Energy Lasers,” Ann. N.Y. Acad. Sci., vol. 122, May 29, 1965, 1965, pp. 802-833. |
K. Iwasaki et al., (Astract) “Development of Laser Systems for Treatment of Hyperpigmented Skin Lesions,” Publication unknown—entire article is in Japanese except for the Abstract, revised Mar. 1, 1989, pp. 26-34 (Abstract appears on p. 34). |
Brochure by SCITON, “PROFILE™ Combination Long Pulse Erbium and Long Pulse Nd:YAG 1064,” website http://www.sciton.com/public/profile.htm, printed Jul. 15, 2003, 2 pages in length. |
Chen, S. S. (1998). “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Pseudoelastic Behavior at 37° C,” Journal of Biomechanics 31:211-216. |
Dover, J. S. et al. (Sep. 1996). “Laser Skin Resurfacing,” Seminars in Cutaneous Medicine and Surgery 15(3):177-188. |
Ross, E. V. et al. (Nov. 1997). “Long-Term Results After CO2 Laser Skin Resurfacing: A Comparison of Scanned and Pulsed Systems,” Journal of the American Academy of Dermatology 37(5):709-718. |
Number | Date | Country | |
---|---|---|---|
20050049658 A1 | Mar 2005 | US |
Number | Date | Country | |
---|---|---|---|
60540981 | Jan 2004 | US | |
60497745 | Aug 2003 | US |